GET THE APP

SEF classifi cation for COPD management
..

Pulmonary & Respiratory Medicine

ISSN: 2161-105X

Open Access

SEF classifi cation for COPD management


3rd International Conference on Chronic Obstructive Pulmonary Disease

July 11-12, 2016 Brisbane, Australia

Md Rashidul Hassan, and Md Ali Hossain

National Institute of Diseases of the Chest & Hospital, Dhaka, Bangladesh

Scientific Tracks Abstracts: J Pulm Respir Med

Abstract :

Chronic Obstructive Pulmonary Disease (COPD) is one of the most common respiratory ailments encountered by the physicians. Th is disease is a burden for both developed and developing countries. In 2007, a study on COPD known as BOLD-BD (Burden of Obstructed Lung Disease in Bangladesh) revealed the prevalence of COPD in general population to be 4.32% Chronic Obstructive Lung Diseases (COPD) may cause signifi cant infl ammation and narrowing of small airways which is not refl ected very well by FEV1. Moreover, FEV1 correlated well with exertional dyspnea, not with chronic productive cough even with wheeze. Patients with chronic productive cough are more prone to exacerbations than emphysema patient, so management of Chronic Obstructive Lung Diseases (COPD) depends on both symptoms and exacerbations besides FEV1. GOLD classifi cation ABCD sub-classifi cation is not friendly for GPs. Considering limitations of FEV1, presence of complications (respiratory failure, other comorbidities), frequency of exacerbations and impact of disease on patients� life a new management plan for Chronic Obstructive Lung Diseases (COPD) patients is formulated which is more eff ective than Gold management plan. So, a modifi ed staging and management of Chronic Obstructive Lung Diseases (COPD) is formulated which is based on symptoms (S) frequency of exacerbations (E) and Function (Lung Function= FEV1) and depending on these three parameters, SEF(symptom, exacerbation and Function) classifi cation has been made. According to SEF classifi cation, COPD patients are dividing into four stages on the basis of FEV1 and each stage is again sub-classifi ed on the basis of symptoms (a) and exacerbation (b)

Biography :

Prof. Md. Rashidul Hassan Director cum Professor, National Institute of Diseases of the Chest & Hospital, Dhaka 1212 is a Bangladeshi, completed his MD Respiratory Medicine from Dhaka University in the Year 1995. He is now Professor, Department of Respiratory Medicine, National Institute of Diseases of the Chest and Hospital [NIDCH], Dhaka 1212, Bangladesh. He is now Founding President of Bangladesh Lung Foundation and Founding Vice President of Evidence Based Clinical Practice Society of Bangladesh. He has published 63 papers in reputed Journals and has been serving as editorial board member of Journal of Asia Pacifi c Society of Respirology (APSR)

Email: mrhassan07@gmail.com

Google Scholar citation report
Citations: 1690

Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report

Pulmonary & Respiratory Medicine peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward